{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T14:54:14Z","timestamp":1782226454634,"version":"3.54.5"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["NIMR\/IEC-M\/2023\/970\/v6-May\/05"],"award-info":[{"award-number":["NIMR\/IEC-M\/2023\/970\/v6-May\/05"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.clinthera.2025.11.006","type":"journal-article","created":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T04:06:39Z","timestamp":1765685199000},"page":"104-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and safety of Monoclonal Antibodies in Malaria Protection and Prevention of Transmission: A Systematic Review"],"prefix":"10.1016","volume":"48","author":[{"given":"Kanika","family":"Verma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richa","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anup","family":"Anvikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen Kumar","family":"Bharti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1455-6504","authenticated-orcid":false,"given":"Nitika","family":"Nitika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2025.11.006_bib0001","unstructured":"World Health Organization. World malaria report 2024. https:\/\/www.who.int\/teams\/global-malaria-programme\/reports\/world-malaria-report-2024. (Last accessed on 7-October-2025)"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0002","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s44197-024-00228-2","article-title":"Current status of malaria control and elimination in Africa: epidemiology, diagnosis, treatment, progress and challenges","volume":"14","author":"Li","year":"2024","journal-title":"J Epidemiol Glob Health"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0003","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/ncomms1879","article-title":"Estimating the potential public health impact of seasonal malaria chemoprevention in African children","volume":"3","author":"Cairns","year":"2012","journal-title":"Nat Commun"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0004","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nrmicro2331","article-title":"Artemisinin resistance: current status and scenarios for containment","volume":"8","author":"Dondorp","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0005","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4103\/1995-7645.388384","article-title":"Malaria slide bank plays a crucial role in achieving and sustaining malaria elimination in India","volume":"16","author":"Nema","year":"2023","journal-title":"Asian Pac J Trop Med"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0006","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/s41390-025-03967-5","article-title":"Malaria in pregnancy and its potential impact on neurodevelopment in children: a systematic review","volume":"98","author":"Nema","year":"2025","journal-title":"Pediatr Res"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0007","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/trstmh\/traf029","article-title":"Plasmodium falciparum histidine-rich protein 2\/3 gene deletions and repeat motifs in Chhattisgarh, India (2017\u20132018)","volume":"119","author":"Nema","year":"2025","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157949","article-title":"Prevalence of pfhrp2 and\/or pfhrp3 gene deletion in Plasmodium falciparum population in eight highly endemic states in India","volume":"11","author":"Bharti","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0009","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/trstmh\/traf008","article-title":"From relief to resistance: implications of self-medication practice for malaria elimination in India","volume":"119","author":"Verma","year":"2025","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmmb.2024.100691","article-title":"Mutations in Plasmodium falciparum Kelch13 (PfK13) dysregulates PI3K\/AKT signalling pathway in artemisinin resistance","volume":"51","author":"Verma","year":"2024","journal-title":"Indian J Med Microbiol"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0011","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1056\/NEJMoa2206966","article-title":"Safety and efficacy of a monoclonal antibody against malaria in Mali","volume":"387","author":"Kayentao","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0012","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1056\/NEJMoa2312775","article-title":"Subcutaneous administration of a monoclonal antibody to prevent malaria","volume":"390","author":"Kayentao","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0013","doi-asserted-by":"crossref","unstructured":"Venkatraman N, Tiono AB, Bowyer G, et al. Phase I assessments of first-in-human administration of a novel malaria anti-sporozoite vaccine candidate, R21 in matrix-M adjuvant, in UK and Burkinabe volunteers. Preprint. Posted October 18, 2019. medRxiv. https:\/\/doi.org\/10.1101\/19009282.","DOI":"10.1101\/19009282"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0014","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4103\/1995-7645.378560","article-title":"R21 vaccine: a ray of hope for malaria elimination","volume":"16","author":"Nitika","year":"2023","journal-title":"Asian Pac J Trop Med"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0015","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s43856-023-00373-y","article-title":"Modeling of malaria vaccine effectiveness on disease burden and drug resistance in 42 African countries","volume":"3","author":"Hamilton","year":"2023","journal-title":"Commun Med (Lond)"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0016","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.3390\/v15112177","article-title":"Development of therapeutic monoclonal antibodies for emerging arbovirus infections","volume":"15","author":"Ormundo","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0017","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s43856-025-00968-7","article-title":"A comprehensive overview of the burden, prevention, and therapeutic aspects of arboviral diseases in India","volume":"5","author":"Gupta","year":"2025","journal-title":"Commun Med (Lond)"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0018","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S1473-3099(22)00793-9","article-title":"Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): a phase 1, adaptive trial","volume":"23","author":"Lyke","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0019","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/trstmh\/trad027","article-title":"Monoclonal antibody: future of malaria control and prevention","volume":"117","author":"Nema","year":"2023","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0020","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.immuni.2020.08.014","article-title":"A Potent anti-malarial human monoclonal antibody targets circumsporozoite protein minor repeats and neutralizes sporozoites in the liver","volume":"53","author":"Wang","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0021","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1056\/NEJMoa2034031","article-title":"A monoclonal antibody for malaria prevention","volume":"385","author":"Gaudinski","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0022","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.143958","article-title":"Enhancing durability of CIS43 monoclonal antibody by Fc mutation or AAV delivery for malaria prevention","volume":"6","author":"Kisalu","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0023","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1056\/NEJMoa2203067","article-title":"Low-dose subcutaneous or intravenous monoclonal antibody to prevent malaria","volume":"387","author":"Wu","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0024","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41591-023-02659-z","article-title":"A candidate antibody drug for prevention of malaria","volume":"30","author":"Williams","year":"2024","journal-title":"Nat Med"},{"issue":"25","key":"10.1016\/j.clinthera.2025.11.006_bib0025","first-page":"00481-5","article-title":"Human monoclonal antibody MAM01 for protection against malaria in adults in the USA: a first-in-human, phase 1, dose-escalation, double-blind, placebo-controlled, adaptive trial","volume":"S1473-3099","author":"Lyke","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0026","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/S1473-3099(22)00428-5","article-title":"Safety, tolerability, and Plasmodium falciparum transmission-reducing activity of monoclonal antibody TB31F: a single-centre, open-label, first-in-human, dose-escalation, phase 1 trial in healthy malaria-naive adults","volume":"22","author":"Van Der Boor","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0027","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0028","first-page":"7","article-title":"Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better?","volume":"7","author":"Ma","year":"2020","journal-title":"Mil Med Res"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0029","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/s12936-024-05128-1","article-title":"Chemoprevention of malaria with long-acting oral and injectable drugs: an updated target product profile","volume":"23","author":"El Gaaloul","year":"2024","journal-title":"Malar J"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0030","doi-asserted-by":"crossref","first-page":"e199","DOI":"10.1016\/S2214-109X(20)30475-7","article-title":"Seasonal malaria chemoprevention in the Sahel subregion of Africa: a cost-effectiveness and cost-savings analysis","volume":"9","author":"Gilmartin","year":"2021","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0031","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa2026330","article-title":"Seasonal malaria vaccination with or without seasonal malaria chemoprevention","volume":"385","author":"Chandramohan","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0032","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1473-3099(23)00368-7","article-title":"Seasonal vaccination with RTS,S\/AS01E vaccine with or without seasonal malaria chemoprevention in children up to the age of 5 years in Burkina Faso and Mali: a double-blind, randomised, controlled, phase 3 trial","volume":"24","author":"Dicko","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0033","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1186\/s12936-021-03888-8","article-title":"Combining malaria vaccination with chemoprevention: a promising new approach to malaria control","volume":"20","author":"Greenwood","year":"2021","journal-title":"Malar J"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0034","doi-asserted-by":"crossref","first-page":"352","DOI":"10.4103\/ijph.ijph_577_23","article-title":"An exploratory study of seasonal malaria chemoprevention and pharmacovigilance for under-five children in Kebbi State, Nigeria","volume":"67","author":"Gulma","year":"2023","journal-title":"Indian J Public Health"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0035","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/trstmh\/trad042","article-title":"A proposed method of grading malaria chemoprevention efficacy","volume":"117","author":"White","year":"2023","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0036","series-title":"Seasonal Malaria Chemoprevention With Sulfadoxine-Pyrimethamine Plus Amodiaquine in Children: A Field Guide","year":"2023"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0037","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41467-017-02603-z","article-title":"Long-acting injectable atovaquone nanomedicines for malaria prophylaxis","volume":"9","author":"Bakshi","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0038","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0000211","article-title":"Model-informed target product profiles of long-acting-injectables for use as seasonal malaria prevention","volume":"2","author":"Burgert","year":"2022","journal-title":"PLOS Glob Public Health"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0039","doi-asserted-by":"crossref","first-page":"6147","DOI":"10.1128\/AAC.01285-13","article-title":"A novel investigational Fc-modified humanized monoclonal antibody, motavizumab-YTE, has an extended half-life in healthy adults","volume":"57","author":"Robbie","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0040","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/emmm.201201379","article-title":"Fc-fusion proteins: new developments and future perspectives","volume":"4","author":"Czajkowsky","year":"2012","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0041","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1124\/dmd.119.086488","article-title":"Mechanisms influencing the pharmacokinetics and disposition of monoclonal antibodies and peptides","volume":"47","author":"Datta-Mannan","year":"2019","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0042","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2020.1829337","article-title":"Pharmacokinetics of novel Fc-engineered monoclonal and multispecific antibodies in cynomolgus monkeys and humanized FcRn transgenic mouse models","volume":"12","author":"Valente","year":"2020","journal-title":"mAbs"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0043","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2147\/CEG.S521893","article-title":"Optimising monoclonal antibody drug development for inflammatory bowel disease","volume":"18","author":"Colwill","year":"2025","journal-title":"Clin Exp Gastroenterol"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0044","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12960-022-00739-8","article-title":"Rapid scale-up of COVID-19 training for frontline health workers in 11 African countries","volume":"20","author":"Tsiouris","year":"2022","journal-title":"Hum Resour Health"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0045","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/hcs2.117","article-title":"The African medicines agency and medicines regulation: progress, challenges, and recommendations","volume":"3","author":"Abdulwahab","year":"2024","journal-title":"Health Care Sci"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0046","series-title":"International Ethical Guidelines for Health-Related Research Involving Humans","year":"2017"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0047","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.actatropica.2005.06.011","article-title":"Ethical perspective on malaria research for Africa","volume":"95","author":"Kilama","year":"2005","journal-title":"Acta Trop"},{"issue":"25","key":"10.1016\/j.clinthera.2025.11.006_bib0048","first-page":"00534-1","article-title":"A new monoclonal in the arMAMentarium against malaria","volume":"S1473-3099","author":"Lorenz","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.clinthera.2025.11.006_bib0049","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12936-024-05222-4","article-title":"Therapeutic development to accelerate malaria control through intentional intervention layering","volume":"24","author":"Braunack-Mayer","year":"2025","journal-title":"Malar J"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014929182500390X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014929182500390X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T14:23:39Z","timestamp":1769610219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014929182500390X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S014929182500390X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2025.11.006","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of Monoclonal Antibodies in Malaria Protection and Prevention of Transmission: A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2025.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}